Combination of Circulating miR-125a-5p, miR-223-3p and D-dimer as a Novel Biomarker for Deep Vein Thrombosis

• Published in: The American journal of the medical sciences Vol. 364; no. 5; p. 601
• Main Authors: Xu, Luoluo, Ji, Changhua, Miao, Xiangling, Ge, Junfeng, Li, Fandong, Xu, Chengwei
• Format: Journal Article
• Language: English
• Published: United States 01.11.2022
• Subjects: Biomarkers - blood; Humans; MicroRNAs - blood; MicroRNAs - genetics; Pulmonary Embolism - etiology; ROC Curve; Venous Thrombosis - blood; Venous Thrombosis - complications; Venous Thrombosis - diagnosis; Venous Thrombosis - genetics; Circulating miRNAs; Venous thrombosis; Diagnosis; Biological markers
• ISSN: 1538-2990
• DOI: 10.1016/j.amjms.2022.04.033

Deep venous thrombosis (DVT) is a thrombus formed in the deep venous cavity and can cause a fatal pulmonary embolism. Since circulating miRNAs are used as molecular markers for the early warning and diagnosis of various diseases, such as tumors and cardiovascular diseases, the purpose of the present study was initially to identify differential expression circulating miRNAs in plasma, and then explore potential biomarkers for DVT. The plasma of 30 patients with DVT before and after DVT-related endovascular interventions constituted 6 sample pools for miRNA sequencing, and the levels of 22 plasma miRNAs were significantly changed. Then, various bioinformatics tools were utilized to screen out 8 miRNAs with potential DVT diagnostic value. Furthermore, their diagnostic values were evaluated in 120 patients with DVT and 120 healthy individuals. The levels of 22 circulating plasma miRNAs (12 up-regulated, 10 down-regulated) were significantly changed in patients with DVT before and after endovascular interventions, especially miR-125a-5p (up-regulation) and miR-223-3p (down-regulation). The values of area under the ROC curve (AUC) of miR-125a-5p and miR-223-3p were both >0.8, indicating that they were valuable in diagnosing DVT. The combination of miR-125a-5p and miR-223-3p with D-dimer significantly improved the efficiency of diagnosing DVT, (AUC >0.97, the sensitivity and specificity >95%), and was better than those of D-dimer alone. The levels of miR-125a-5p and miR-223-3p were the most significantly changed in patients with DVT before and after endovascular interventions; together with the classic biomarker D-dimer, they can be used as a potential biomarker for diagnostic and therapeutic process of DVT.